CompaniesAP Biosciences

AP Biosciences

active
Taipei, Taiwan
Founded 2013
Website
About

Bispecific Antibodies

Areas of Focus

Categories

Biologics & BiopharmaceuticalAntibodyTaiwan
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

4

As Collaborator

0

Total Enrollment

324

By Phase

PHASE1: 2PHASE1/PHASE2: 2

By Status

RECRUITING: 2NOT_YET_RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
2028
2029
Today
NCT06723964
NCT05473156
NCT06669975
NCT07165067
Hover over trial bars to see details

Recent Trials

NCT07165067Lead Sponsor
A Study of AP601 in Patients With Locally Unresectable Advanced or Metastatic Solid Tumors
PHASE1Not yet recruiting
36 participants
Started: Sep 20, 2025 · Completed: Jan 30, 2028
NCT06669975Lead Sponsor
A Study of AP402 in HER2-Positive Patients With Locally or Advanced Solid Tumors
PHASE1/PHASE2Recruiting
85 participants
Started: Apr 22, 2025 · Completed: Dec 1, 2027
NCT05473156Lead Sponsor
A Study to Investigate the Safety, Pharmacokinetics, and Clinical Activity of AP203 in Patients with Locally Advanced or Metastatic Solid Tumors, and Expansion to Selected Malignancies
PHASE1/PHASE2Recruiting
168 participants
Started: Jul 24, 2023 · Completed: Dec 31, 2027
NCT06723964Lead Sponsor
A Study of AP505 Injection in Patients With Advanced Malignant Solid Tumors
PHASE1Active, not recruiting
35 participants
Started: Mar 30, 2023 · Completed: Nov 30, 2025
Locations (1)
Headquarters
Taipei, Taiwan
Map

Loading map...